"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...

CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if ...

Secretary Robert F. Kennedy Jr. to disclose details about several private dinners he attended with Donald Trump and ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

The same business leaders who are publicly cordial to Donald Trump—even to his face—privately bemoan the havoc the ...

A much-anticipated meeting between President Donald Trump and representatives of the pharmaceutical industry took place ...

Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...

Pfizer CEO Albert Bourla announced the possibility of shifting overseas manufacturing to U.S. plants. This response is due to ...

(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in ...

U.S. President Donald Trump has issued a memorandum directing federal agencies to restrict inbound and outbound investments ...

Pfizer CEO Albert Bourla said on Monday that the drugmaker can shift manufacturing for the US market to its existing plants in the US, as the threat of tariffs puts a question mark over global supply ...

An icon in the shape of a lightning bolt. Impact Link Albert Bourla, Pfizer's CEO, said on Monday that the company may move overseas drug manufacturing back to the US if President Donald Trump's ...